Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks to slip early on
(Sharecast News) - UK stocks were expected to slip again on Friday on a busy day for economic data as investors continue to digest central bank decisions across the globe. Futures were pointing to a 0.3% fall on the FTSE 100 in pre-market trade after a tumultuous week for markets, which saw policymakers in the US and UK hold interest rates steady but give hawkish outlooks with inflation still well above the target range. A total of six of the G10 central banks reported monetary policy decisions this week.
Markets in the US slumped on Thursday, with the S&P 500 and Nasdaq both dropping to a three-month low, as rising bond yields cemented expectations that monetary policy would stay tighter for longer.
The yield on a 10-year US Treasury briefly surpassed the 4.5% level, its highest since 2007, while two-year yields were at their highest since 2006, and the 30-year yield rose to its 2011 high.
Friday sees the release of a host of purchasing managers' indices (PMIs) from Germany, the UK and the US.
Other data revealed that UK retail sales rebounded in August from the rain affected prior month, rising 0.4% on the back of strong food and clothing purchases by consumers. This was an improvement from the 1.1% decline in July but slightly below the 0.5% increase expected by analysts.
Meanwhile, the GfK Consumer Confidence Index increased four points to -21, the highest reading since January 2022.
In company news, Investec on Friday said it expected to post higher earnings for the first half of the year, boosted by the now-completed merger of its UK wealth and investment business with Rathbones, higher global interest rates and growth in average lending books. Adjusted pre-tax operating for the six months to August 31 was expected to be in a range of £428.7m- £449.6m, compared with £405m a year ago.
AstraZeneca announced positive results from the TROPION-Breast01 phase three trial on Friday, where datopotamab deruxtecan showed significant improvement in progression-free survival compared to standard chemotherapy in patients with specific types of metastatic breast cancer. While there was a trend towards improved overall survival with datopotamab deruxtecan, data was not yet conclusive, and the trial would continue to assess this. The drug, jointly developed with Daiichi Sankyo, had a safety profile consistent with past tests.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.